Hong Liu

8PUBLICATIONS
13CO-AUTHORS
NanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 03, 2026
Layered Lipid Nanoparticle Adjuvants Coordinate Toll-Like Receptor 4 and Toll-Like Receptor 9 Activation with Enhanced Immunity and Improved Tolerability.

|Jul 07, 2026
A Lung-Targeted γδ T Cell Nanovaccine Couples Pulmonary Immune Priming to Systemic Antitumor Immunity in Non-Small-Cell Lung Cancer.

|Mar 13, 2026
Mucosal-Penetrating Nanovaccine Enhances Mucosal and Systemic Immunity against Respiratory Syncytial Virus Infection.

Zhihui Zhang, Haolin Chen, Beibei Xu

|Mar 02, 2026
Unraveling the Role of Ionizable Lipid Isomerism in Modulating Lipid Nanoparticles for mRNA Delivery.

Zepeng He, Zhijia Liu, Taisen Zuo

|May 16, 2025
Exaggerated Lung Inflammation Induced by Lung-Targeted mRNA-LNP Dampens Vaccines against Tuberculosis.

Liyan Li, Zeyu Yang, Hong Liu

|May 10, 2025
Enhanced Transdermal Delivery of Liraglutide for Sustained Obesity Management.

Nipeng Chen, Zhipeng Zeng, Haolin Chen

Pageof 2

Frequent Collaborators

7 joint publications

Lixin Liu

7 joint publications

Yongming Chen

3 joint publications

Zhijia Liu

1 joint publications

Xiang Li